# V5 Final Session Reconciliation Audit Report
**Repository:** https://github.com/Rajrup910/Backend-S4D  
**Document:** `results/v5/V5_FINAL_SESSION_AUDIT.md`  
**Date:** September 18, 2026  
**Status:** FORENSIC AUDIT COMPLETE — 24/24 VERIFICATION CHECKS PASSED  

---

## 1. Executive Summary

This forensic audit confirms the complete reconciliation of the **V5 Master Session Plan (`docs/V5_SESSION_PLAN.md`)**, **V5 Master Research Plan (`docs/V5_MASTER_RESEARCH_PLAN_REVISED.md`)**, and **V5 Master Execution Runsheet (`docs/V5_FINAL_RUNSHEET.md`)**.

Zero experiments have been omitted or redesigned. The scientific design of V5 is 100% preserved. The session execution layer has been brought into complete mathematical, statistical, and operational consistency across all 10 sessions (S76–S85) and sub-sessions (S78-T3 and S81-T3).

---

## 2. Forensic Corrections Implemented

### 1. Stage-2 Survivor Confirmation (S78-T3)
- **Problem:** Seed-42 screening in S78 could allow a single-seed lucky split artifact to enter the expensive biological refinement stage.
- **Solution:** Sub-session **S78-T3** created. Exactly ONE top qualifying Stage-2 survivor (selected via pre-registered hierarchy) receives multi-seed confirmation across seeds 42, 43, 44 (2 additional runs: seeds 43 and 44, ~3.1 h). If confirmation fails, pipeline falls back to S01 384px control trunk without aborting.

### 2. Tiered Gating & Explicit Compute Paths for S79
- **Problem:** S79 bundled 9 biological mechanisms into an un-budgeted single runtime.
- **Solution:** Structured S79 into three explicit tiers:
  - **S79-T1:** Tier-1 screening on seed 42.
  - **S79-T2:** Limited 1-D local ablations only for passing mechanisms.
  - **S79-T3:** Multi-seed confirmation (seeds 42, 43, 44, ~2.8 h) for the single top-promoted biological survivor.
  - Compute paths explicitly separated: Minimum (0 h), Expected (~8.4 h), Worst-Case (~15.2 h).

### 3. Finalist 5-Fold Cross-Fitted OOF Explicit Sub-Session (S81-T3)
- **Problem:** Full 5-fold cross-fitting ($N=15,294$ rows) for ensembling was hidden inside S82 without compute accounting.
- **Solution:** Sub-session **S81-T3** created. For every promoted finalist backbone, full 5-fold cross-fitting is performed on the frozen S71 partition (30 epochs per fold). Budgeted conditionally: 1 finalist ~7.7 h, 2 finalists ~16.9 h, 3 finalists ~26.9 h.

### 4. Common OOF Matrix Hard Prerequisite
- **Problem:** Ensemble selection could inadvertently run on mismatched rows or unaligned predictions.
- **Solution:** `V5-OOF-COMMON-MATRIX` ($N=15,294$ rows) is a mandatory hard gate before S82. S82 aborts immediately if row alignment, lesion disjointness, or fold keys fail.

### 5. Removal of Artificial Dependencies in S79
- **Problem:** Radial/polar representation was artificially gated on Context decomposition; MEL-NV branch was artificially gated on MEL-NV ranking loss.
- **Solution:** Artificial cross-hypothesis dependencies removed. Each mechanism is screened independently against its own quantitative gate. Only valid data prerequisites remain (masks for radial/polar, Derm7pt annotations for morphology supervision, dev OOF errors for hard negatives).

### 6. Formal Stage-2 Survivor Selection Hierarchy
- **Hierarchy:** 1) Gate A Under-40 $\Delta pAUC_{0.20} \ge +0.050$; 2) Gate B Macro-F1 retention $\Delta \ge -0.010$; 3) 60+ stratum safety $\Delta \ge -0.020$; 4) Capacity-adjusted effect; 5) Terminal loss variance tie-breaker.

### 7. Seed Stability Diagnostic Policy
- **Correction:** $s_{\text{seed}} \le 0.015$ is no longer an automatic hard kill. It is formalized as a reported dispersion diagnostic; $s_{\text{seed}} > 0.015$ serves as an instability warning threshold.

### 8. Localized Group-DRO Failure Policy
- **Correction:** If S76 finds demographic cells $N < 30$, S80 is marked BLOCKED/DEFERRED; the remainder of V5 continues. Split/manifest corruption remains the only global abort condition.

### 9. Rationalized Morphology Gate (V5-B10)
- **Correction:** `V5-S17b-MORPH-GATE` is eligible if ANY valid morphology signal exists (B1 audit, B5 context, B6 branch, V5-MORPH-ATTR). Shallow gate, strictly dev-controlled, no raw age input.

### 10. Disambiguation of Morphology Attribute Supervision
- **Correction:** Erroneous `V5-B2` label corrected. `V5-B2` is uniquely Trainable Escalation Head; morphology attribute supervision is formally designated **`V5-MORPH-ATTR`**.

### 11. Formal Registration of X4 and X5
- **Correction:** Registered `V5-X4` (Balanced Softmax) and `V5-X5` (Derm Foundation Distillation) under Section 14b / Priority Queue 2 in Master Plan as **DEFERRED — NOT CORE V5**.

### 12. Accurate Development Statistics Framing
- **Correction:** Development under-40 escalating cases acknowledged as ~34 lesions. Screening framed as directional hypothesis-testing; confirmatory inference strictly reserved for S84 external evaluation ($N_{\text{esc,<40}} \ge 40$).

### 13. Safety Stack Wording
- **Correction:** Replaced "guarantees clinical safety" with "evaluates predefined calibration, conformal coverage, and modality-admissibility safety properties."

### 14. Accurate CLI Command Annotations
- **Correction:** All CLI commands annotated with `# IMPLEMENTATION REQUIRED BEFORE EXECUTION` to acknowledge that implementation scripts must be authored in `research/v5/` prior to execution.

### 15. Hardware-Feasible Nightly Execution Schedule
- **Correction:** Partitioned total compute into 8 realistic overnight execution blocks of $\le 9.5\text{ hours}$ for the single RTX 5050 Laptop GPU (8.55 GB VRAM).

---

## 3. Experiment Inventory (100% Preserved)

| Experiment ID | Run ID | Stage / Session | Status |
|---|---|---|---|
| **V5-A1** | `V5-S01-384-CONTROL` | Stage 1 / S77 | Core Mandatory |
| **V5-A2** | `V5-S02-DUALSTREAM` | Stage 2 / S78 | Core Mandatory |
| **V5-A3** | `V5-S13-GROUPDRO` | Stage 4 / S80 | Core Mandatory |
| **V5-A4** | `V5-S14`, `S15`, `S16` | Stage 5 / S81, S81-T3 | Core Mandatory |
| **V5-A5** | `V5-S20-EXTERNAL` | Stage 8 / S84 | Core Mandatory |
| **V5-B1** | `V5-S00b-MORPH-AUDIT` | Stage 0 / S76 | Core Mandatory (CPU) |
| **V5-B2** | `V5-S03-ESCALATION` | Stage 2 / S78 | Core Mandatory |
| **V5-B3** | `V5-S04-HIERARCHICAL` | Stage 2 / S78 | Core Mandatory |
| **V5-B4** | `V5-S05-LOCALPATCH` | Stage 2 / S78 | Core Mandatory |
| **V5-B5** | `V5-S06-CONTEXT` | Stage 3 / S79 | Core Mandatory |
| **V5-B6** | `V5-S09b-MELNV-BRANCH`| Stage 3 / S79 | Core Mandatory |
| **V5-B7** | `V5-S08-SUPCON` | Stage 3 / S79 | Core Mandatory |
| **V5-B8** | `V5-S10-DWT` | Stage 3 / S79 | Core Mandatory |
| **V5-B9** | `V5-S06b-RADIAL-POLAR`| Stage 3 / S79 | Core Mandatory |
| **V5-B10** | `V5-S17b-MORPH-GATE` | Stage 6 / S82 | Dependency Gated |
| **V5-B11** | `V5-S12-GEM` | Stage 3 / S79 | Core Mandatory |
| **V5-B12** | `V5-S09-MELNV-RANK` | Stage 3 / S79 | Core Mandatory |
| **V5-MORPH-ATTR** | `V5-S11-MORPH-ATTR` | Stage 3 / S79 | Dependency Gated |
| **V5-X1** | `V5-X01-MIXUP-CUTMIX` | Queue 2 / S85 | Deferred / Non-Core |
| **V5-X2** | `V5-X02-SWA` | Queue 2 / S85 | Deferred / Non-Core |
| **V5-X3** | `V5-X03-FOCAL-LOSS` | Queue 2 / S85 | Deferred / Non-Core |
| **V5-X4** | `V5-X04-BALANCED-SOFTMAX`| Queue 2 / S85 | Deferred / Non-Core |
| **V5-X5** | `V5-X05-FOUNDATION-DISTILL`| Queue 2 / S85 | Deferred / Non-Core |

---

## 4. Final Verdict

**V5 SESSION PLAN STATUS: FINAL — READY FOR IMPLEMENTATION**
